← Biofrontera Inc.

Annual Trend FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Net Income From Continuing Operations — — ($640k) ($20.1m) ($17.8m) ($10.5m)
Net Income (Loss) Attributable to Parent ($11.0m) ($37.7m) ($640k) ($20.1m) ($17.8m) ($10.5m)
Net Income (Loss) Available to Common Stockholders, Basic ($11.0m) ($37.7m) ($640k) ($20.1m) ($17.8m) ($10.5m)
Depreciation, Depletion and Amortization — — $754k $646k $600k $138k
Depreciation $144k $122k $101k $86k $92k $100k
Amortization of Intangible Assets $418k $418k $418k $418k $329k —
Depreciation Expense $144k $122k $101k $86k $92k $138k
Amortization Cash Flow — $418k $418k $418k $329k —
Amortization Of Intangibles — $418k $418k $418k $329k —
Depreciation Amortization Depletion — — $1.2m $1.1m $1.1m $868k
Share-based Payment Arrangement, Noncash Expense — $129k $1.9m $1.0m $1.0m $951k
Gain (Loss) on Sale of Assets and Asset Impairment Charges — — — — — $700k
Impairment of Intangible Assets, Finite-lived — — — — — $0
Gain (Loss) on Extinguishment of Debt — — — — ($316k) —
Income (Loss) from Equity Method Investments — — $1.7m ($7.4m) ($14k) $2k
Income Tax Expense (Benefit) $64k $56k $32k $14k $22k $25k
Other Nonoperating Income (Expense) $1.6m $689k $33k ($75k) $158k $388k
Non-cash interest expense $358k $358k $358k $402k $297k $491k
Operating lease liabilities — — ($781k) ($657k) ($689k) ($683k)
Interest Expense — $2k $1k $125k $1.7m $6k
Income Tax Expense $64k $56k $32k $15k $24k $25k
Changes in operating assets and liabilities:
Additional Financial Items
Increase (Decrease) in Accounts Receivable ($1.2m) $612k $70k $1.5m $315k $1.9m
Increase (Decrease) in Inventories $273k ($2.6m) $2.8m $3.8m ($4.2m) ($1.4m)
Asset Acquisition Contingent Consideration Liability $7.6m $6.2m $2.4m — — —
Equity Securities, FV-NI, Gain (Loss) — — — ($7.4m) ($14k) —
Equity Securities, FV-NI, Realized Gain (Loss) — — — $7.2m $98k —
Equity Securities, FV-NI, Unrealized Gain (Loss) — — — ($202k) ($84k) —
Gain (Loss) on Investments — — $1.7m ($7.4m) ($14k) $2k
Gain (Loss) Related to Litigation Settlement — — — $7.4m — —
General and Administrative Expense — — — — $16.3m $22.9m
Inventory Write-down $401k $33k $100k — — —
Investment Income, Interest $28k $16k — — $71k —
Nonoperating Income (Expense) ($1.3m) ($12.5m) $18.0m $2.6m ($527k) $837k
Operating Expenses $28.5m $49.3m $47.3m $56.7m — $53.1m
Restructuring Costs $1.1m $800k $0 — — —
Net loss ($11.0m) ($37.7m) ($640k) ($20.1m) ($17.8m) ($10.5m)
Stock-Based Compensation Expense — $129k $1.9m $1.0m $1.0m $951k
Provision for Doubtful Accounts (CF) ($16k) $44k $106k $122k $162k ($69k)
Realized/unrealized loss in investment, related party — — ($1.7m) $7.4m $14k ($2k)
Accounts receivable $1.2m ($612k) ($70k) ($1.5m) ($315k) ($1.9m)
Other receivables, related party — ($11.4m) $5.0m $6.5m $2k —
Prepaid expenses and other assets $364k ($3.8m) $4.2m $174k ($141k) ($1.7m)
Other assets, related party — — — ($5.2m) $5.2m ($686k)
Inventories ($273k) $2.6m ($2.8m) ($3.8m) $4.2m $1.4m
Change in Accounts Payable ($3.4m) ($773k) $912k ($6.4m) ($230k) $610k
Accounts payable, related parties, net — — — $4.4m ($355k) ($533k)
Cash flows provided by (used in) investing activities — ($11k) ($5.2m) $619k ($3k) $3.0m
Proceeds from issuance of Series B-1 preferred stock and warrants to purchase series B-3 preferred stock, net of issuance costs — — $9.4m $4.5m $7.7m —
Cash flows provided by financing activities $13.2m $43.2m $14.0m $8.4m $14.8m $10.8m
Beginning Cash Position — — $24.7m $17.4m $1.5m $6.1m
Cash Flow From Continuing Financing Activities — — $14.0m $8.4m $14.8m $10.8m
Cash Flow From Continuing Investing Activities — — ($5.2m) $619k ($3k) $3.0m
Change In Account Payable — ($773k) — $6.4m ($1.8m) ($535k)
Change In Accrued Expense — — ($3.6m) ($6.4m) ($230k) $610k
Change In Inventory — — ($2.8m) ($3.8m) $4.2m $1.4m
Change In Other Current Assets — — $0 ($5.2m) $5.2m ($686k)
Change In Other Current Liabilities — — ($781k) ($657k) ($689k) ($683k)
Change In Payable — — $912k $6.4m ($1.8m) ($535k)
Change In Payables And Accrued Expense — — ($2.7m) $64k ($2.0m) $75k
Change In Prepaid Assets — — $4.2m $174k ($141k) ($1.7m)
Change In Receivables — — $4.9m $4.9m ($313k) ($1.9m)
Change In Working Capital — — $2.8m ($4.4m) $6.2m ($3.5m)
Changes In Account Receivables — — ($70k) ($1.5m) ($315k) ($1.9m)
Changes In Cash — — ($7.3m) ($15.9m) $4.6m $487k
End Cash Position — — $17.4m $1.5m $6.1m $6.6m
Financing Cash Flow — — $14.0m $8.4m $14.8m $10.8m
Free Cash Flow — — ($16.2m) ($24.9m) ($10.3m) ($13.4m)
Gain Loss On Investment Securities — — ($16.4m) $4.3m ($1.7m) ($901k)
Gain Loss On Sale Of PPE — — — — $0 ($700k)
Investing Cash Flow — — ($5.2m) $619k ($3k) $3.0m
Issuance Of Capital Stock — — $9.4m $4.5m $7.7m $10.8m
Net Intangibles Purchase And Sale — — — $0 ($50k) $0
Net PPE Purchase And Sale — — ($38k) ($5k) ($10k) ($2k)
Net Preferred Stock Issuance — — — $0 $7.7m $10.8m
Operating Gains Losses — — ($16.4m) $4.3m ($1.4m) ($1.6m)
Other Non Cash Items — — ($3.4m) ($6.9m) $297k $510k
Preferred Stock Issuance — — — $0 $7.7m $10.8m
Proceeds From Stock Option Exercised — — $4.6m $0 $7.4m $0
Provisionand Write Offof Assets — — $206k $122k $162k ($69k)
Purchase Of Intangibles — — — $0 ($50k) $0
Purchase Of PPE — — ($38k) ($5k) ($10k) ($2k)
Stock Based Compensation — — $1.9m $1.0m $1.0m $951k
Unrealized Gain Loss On Investment Securities — $0 ($1.7m) $7.4m — —
Net Cash Provided by (Used in) Operating Activities ($12.4m) ($26.7m) ($16.2m) ($24.9m) ($10.3m) ($13.4m)
Cash flows from investing activities:
Payments to Acquire Property, Plant, and Equipment — ($11k) ($38k) $5k $10k $2k
Net Investment Purchase And Sale — — ($5.1m) $624k $57k $0
Purchase Of Investment — $0 ($5.1m) $0 — —
Sale Of Investment — — $0 $624k $57k $0
Net Cash from Investing Activities — — — $624k $57k —
Net Cash Provided by (Used in) Investing Activities — ($11k) ($5.2m) $619k ($3k) $3.0m
Cash flows from financing activities:
Issuance Of Debt — $0 $0 $25.2m $4.0m —
Long Term Debt Issuance — $0 $0 $21.4m — —
Net Issuance Payments Of Debt — — $0 $3.9m ($265k) $0
Net Long Term Debt Issuance — $0 $0 $21.4m — —
Net Short Term Debt Issuance — — $0 $3.9m ($265k) $0
Short Term Debt Issuance — — $0 $25.2m $4.0m —
Payment of principal short-term debt — — — ($21.3m) ($4.3m) —
Repayment Of Debt — — — ($21.3m) ($4.3m) $0
Short Term Debt Payments — — — ($21.3m) ($4.3m) $0
Proceeds from Issuance of Common Stock — $14.9m — — — —
Common Stock Issuance — $29.9m $9.4m $4.5m $0 —
Net Common Stock Issuance — $29.9m $9.4m $4.5m $0 —
Net Cash Provided by (Used in) Financing Activities $13.2m $43.2m $14.0m $8.4m $14.8m $10.8m
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $825k $16.5m ($7.3m) ($15.9m) $4.6m $487k
Net increase in cash and cash equivalents $825k $16.5m ($7.3m) ($15.9m) $4.6m $487k
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $8.3m $24.7m $17.4m $1.5m $6.1m $6.6m
Cash, cash equivalents and restricted cash, at the beginning of the year $8.3m $24.7m $17.4m $1.5m $6.1m $6.6m
Supplemental disclosure of cash flow information:
Change In Cash Supplemental As Reported — — ($7.3m) ($15.9m) $4.6m $487k
Interest Paid, Excluding Capitalized Interest, Operating Activities — $2k $1k $125k $1.7m $6k
Income Taxes Paid, Net $64k $56k $32k $15k $24k $25k

Data sourced from SEC EDGAR 10-K filings via EdgarTools. Amounts are shown in USD as reported in each fiscal year filing.